Developing advanced models for treating brain tumors
Credentialing next-generation human glioma models for precision therapeutics
This study is working on building better models of aggressive brain tumors to help test new treatments that can more effectively target these tough-to-treat gliomas, aiming to improve options for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11000267 on NIH RePORTER |
What this research studies
This research focuses on creating new human glioma models that accurately represent the biology of aggressive brain tumors. By using advanced techniques like CRISPR genome editing, the team aims to develop models that reflect the complexity and resistance mechanisms of gliomas. These models will help in testing targeted therapies designed to overcome challenges such as the blood-brain barrier and tumor heterogeneity. The goal is to improve the effectiveness of EGFR-targeted treatments for patients with gliomas.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with EGFR-driven gliomas who may benefit from new targeted therapies.
Not a fit: Patients with non-EGFR-driven brain tumors or those who are not eligible for experimental therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with EGFR-driven gliomas, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promise in developing targeted therapies for other types of cancers, but this approach for gliomas is relatively novel and untested.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Miller, Christopher Ryan — University of Alabama at Birmingham
- Study coordinator: Miller, Christopher Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.